Archives: Speakers

Brittney is Director, Head of Supply Chain at Tricida where she is responsible for the clinical supply group managing investigational drug and ancillary supplies for Tricida’s global 1600 patient confirmatory post marketing trial for TRC 101 as well as the commercial supply chain group preparing for the launch of TRC 101 / Veverimer in the later part of 2020. Brittney has more than 12 years of experience working in both technical development and supply chain organizations. Prior to Tricida, she was at Intarcia and Genentech where she managed all aspects of supplying clinical trials. From developing forecasts from protocols, translating these forecasts to manufacturing plans and appropriate inventory levels, assessing the supply status of clinical sites and putting in place delivery plans that take into account production, release and distribution timing to ensure no stock-out situations at clinics, Brittney has extensive experience in forecasting creation and hopes to share those tools with you today. She also managed the commercial supply chain for the Clorox Disinfecting Wipes business, dealing with un-precedented demand changes through the H1N1 flu outbreak.

Francesca is the CEO of Baker Tilly International. She was appointed to the role on 1 June 2022 and is responsible for the network operations for Baker Tilly International, a top ten global accounting network, with member firms in over 140 territories. Francesca has 30 years of experience in professional services, including working in global networks, specialising in cross-border and international business support, with a focus on growth. She has senior leadership experience in mid-market firms and began her career in a Big 4 firm. Her roles have also included Global head of tax, legal, risk, mergers and acquisitions and people & culture. She has led teams based around the world. She has also worked in industry and won awards in the fields of international accounting, private client work and professional lecturing. She has frequently commented on TV, radio and in the press on global developments and the need for diversity of thinking, especially to encourage a broader range of people to take on senior roles and create an environment that helps support this aim. She has sat on several UK Government committees and played an active role in the work of the ICAEW and the CIOT. Francesca is a qualified lawyer, chartered accountant and tax adviser. She lives in the south of England with her husband, three children and two dogs.

Hannah currently leads J.P. Morgan Payments’ Marketing Campaign Strategy for the EMEA region. Equal parts strategist and creative, much of her time is spent thinking about the future of Payments, from the perspective of end users, merchants, and processors, and conveying that in a digestible format for all audiences, regardless of their Payments acumen. Passionate about Gender equity, Hannah Co-Chaired the Gender Network at Barclays, where she founded the Barclays Career Kickstarter, an initiative designed to dispel the misconception of an ‘ideal candidate’ in early careers. The scheme provides resources and advice to students, largely targeting those not yet considering a career in Financial Services, aiming to increase black, female and non-STEM graduate representation. At J.P. Morgan Payments, Hannah has remained passionate about early careers, currently leading the London Payments Apprenticeship programme. Dubbed One to Watch by Brummell Magazine, Hannah is part of a new generation of Payments professionals driving the next phase of change in our industry.

Marc has spent his entire career in the eClinical technologies space, with most of that time focused in the area of IRT. Having spent years on the client services side, Marc has worked with 7 of the top 10 pharmaceutical companies and 6 of the top 7 CROs to design, implement, and maintain IRT solutions across a variety of therapeutic areas. As a Co-founder and Director of Business Development at Suvoda, Marc uses his IRT subject matter expertise to provide creative solutions to customers’ problems, all while growing Suvoda’s business globally. Marc enjoys creating long-lasting relationships with customers and colleagues and loves brokering introductions within his network. Marc is a graduate of Lafayette College with a degree in biochemistry and minor in music.

Isaac Blum is currently the Senior Manager of Clinical Supply at ALX Oncology in South San Francisco, California. Previously, Isaac oversaw clinical supply chain operations at Puma Biotechnology and Sangamo Therapeutics. Isaac is excited about optimizing drug supply operations to help advance innovative, life-saving treatments. He has used his expertise to launch multiple global oncology clinical trials, and enjoys collaborating with others in the field through speaking at conferences and workshops. In his free time, Isaac enjoys hiking, running and spending time with his family.

Phil is a supply chain professional working exclusively in the clinical space for over 15 years. He has managed all aspects of clinical supply, packaging and labeling and distribution, IXRS setup and management. He has worked with the following companies: Rainier Therapeutics Aimmune Therapeutics Myovant Sciences Onyx Pharmaceuticals Elan Pharmaceuticals

Tom is currently serving as a Senior UAT Analyst for Bristol Myers Squibb. Most recently, he worked in clinical systems role for Ultragenyx Pharmaceutical, overseeing IRT, CTMS, eCOA, eConsent, CGM, and wearables systems and processes. Previously, he worked as an IRT senior project manager at Amgen, built and managed international technical support and data management teams, and worked as an IRT project manager, both at endpoint clinical. He has managed projects in the therapeutic areas of hematology & oncology, pain, bone, cardiovascular, and dermatology, from early-phase oncology through post-marketing studies. He graduated summa cum laude with a B.A in Philosophy and History from Florida Gulf Coast University, where he also earned an M.A. in English. He has published several articles on process improvement, change management, and making IRT concepts more accessible to sponsor study management personnel.